SCHEMBL6613660

SCHEMBL6613660

CCOC(=O)c1ccc(OC)c(OC)c1OC

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.59
MEN1 O00255 1/20 0.59
PKM P14618 1/20 0.57
ALDH1A1 P00352 1/20 0.52
TSHR P16473 1/20 0.52
MAPT P10636 4/20 0.50
LMNA P02545 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
GAA P10253 1/20 0.50
CDC25B P30305 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
DPP4 P27487 1/20 0.48
POLB P06746 1/20 0.48
HSD17B2 P37059 1/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
CA14 Q9ULX7 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3470803 0.92 MEN1 (0.52) KMT2AMEN1PKMALDH1A1TSHR
SCHEMBL7437362 0.88 LMNA (0.55) KMT2AMEN1PKMTSHRMAPT
SCHEMBL4823776 0.87 MAPT (0.49) KMT2AMEN1PKMALDH1A1TSHR
SCHEMBL27774545 0.87 KMT2A (0.56) KMT2AMEN1PKMALDH1A1TSHR
SCHEMBL875062 0.87 KMT2A (0.48) KMT2AMEN1PKMALDH1A1TSHR
SCHEMBL7851443 0.85 MAPT (0.50) KMT2AMEN1PKMALDH1A1TSHR
SCHEMBL7535764 0.85 TSHR (0.47) KMT2AMEN1PKMALDH1A1TSHR
SCHEMBL7688461 0.85 KMT2A (0.65) KMT2AMEN1ALDH1A1TSHRMAPT
SCHEMBL10884646 0.84 MAPT (0.51) KMT2AMEN1PKMTSHRMAPT
SCHEMBL27271383 0.84 TSHR (0.57) KMT2AMEN1PKMALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118782903-A Non-aqueous electrolyte, lithium ion battery and diaphragm-free lithium ion battery 重庆太蓝新能源有限公司 2024-10-15 CN disclosed
CN-106977397-A A kind of synthetic method of 3,4,5 trimethoxybenzoic acid 五峰赤诚生物科技股份有限公司 2017-07-25 CN disclosed
CN-101486839-B Conductive polymer composition, solid electrolyte and solid electrolyte capacitor using the conductive polymer ZHENGZHOU TAIDA ELECTRONIC MATERIAL TECHNOLOGY CO LTD 2011-08-17 CN disclosed
CN-101486839-A Conductive polymer composition, solid electrolyte and solid electrolyte capacitor using the conductive polymer ZHENGZHOU TAIDA ELECTRONIC MAT (CN) 2009-07-22 CN disclosed
US-20040063665-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2004-04-01 US disclosed
EP-1373244-A2 SUBSTITUTED BENZOPYRANONES AS TELOMERASE INHIBITORS Pharmacia Italia S.p.A. (IT) 2004-01-02 EP disclosed
US-20020160983-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2002-10-31 US disclosed
WO-2002074036-A2 SUBSTITUTED BENZOPYRANONES AS TELOMERASE INHIBITORS PHARMACIA ITALIA SPA (IT) 2002-09-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020160983-A1 Substituted benzopyranones as telomerase inhibitors TERT, TERF2, TERF2IP KMT2A 1256/4885MEN1 3011/4885PKM 1766/4885
US-20040063665-A1 Substituted benzopyranones as telomerase inhibitors TERT, TERF2, TERF2IP KMT2A 1252/4885MEN1 2989/4885PKM 1781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.